In 2022, the global Intraoperative Radiation Therapy Systems Market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and surgery.
As a recent trend, IORT can also be used to treat earlier stage disorders, for example, breast cancer growth and prostate cancer. The entire demand for intraoperative radiation treatment equipment is expected to increase at a 7.7% CAGR between 2022 and 2032, reaching approximately US$ 126.8 million by 2032.
Intraoperative radiation therapy systems (IORT) used to destroy the microscopic tumor cells after surgery, intraoperative radiation therapy delivers a concentrated dose of radiation to a tumor site immediately after a tumor is removed. Because of differential radiation or intrabeam properties, the spectrum is used to identify the microbial composition inside the cells. IORT is the application of therapeutic stages of radiation to the tumor site.
Key Players
The writer will create content on the general strategies of market players. And then will write the key players in the market are: IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD Inc., Elekta AB, SIT - S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co.,Ltd., GMV, Brainlab AG, and others.
Segmentation
The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:
Get More Details@ https://www.futuremarketinsights.com/reports/intraoperative-radiation-therapy-systems-market
Segmentation based on Disease Indication:
- Brain Tumors
- Breast Cancer
- Gastrointestinal Tumors
- Head & Neck Tumors
- Skin Cancer
- Spinal Metastases
- Others
Segmentation based on End User
- Hospitals
- Specialty Clinics
- Ambulatory & Surgical Centers
- Others
COVID-19 Impact Analysis on Intraoperative Radiation Therapy Market report published by Value Market Research provides a detailed market analysis comprising market size, share, value, growth and trends for the period 2020-2027.
Moreover, this market report also covers regional and country markets in detail.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the intraoperative radiation therapy market include Carl Zeiss AG, Ariane Medical Systems Ltd, Eckert & Ziegler, Elekta AB, GMV, Elekta AB (pub), iCAD Inc. , Xoft, IntraOp Medical, Inc., Sordina Iort Technologies, Varian Medical Systems, Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Intraoperative Radiation Therapy Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/intraoperative-radiation-therapy-market/download-sampleMarket DynamicsThe growing prevalence of cancer and advantages offered by intraoperative radiation therapy is the key driver for the growth of this market.
IORT has several advantages over conventional radiotherapy like high precision, limited treatment time, etc.
Some factors like risk of radiation exposure, unavailability of trained personnel, etc may restraint the growth of the IORT market.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis.
Orbisreserach.Com adds “Global Intraoperative Radiation Therapy Systems Market” To Its Research Database.Description: This report studies the global market size of Intraoperative Radiation Therapy Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Intraoperative Radiation Therapy Systems in these regions.
This report also studies the global Intraoperative Radiation Therapy Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2293847 The following manufacturers are covered in this report, with sales, revenue, market share for each company: IntraOp Medical Carl Zeiss Meditec AG iCAD Market size by Product Breast Cancer Head & Neck Tumors Spinal Metastases Brain Tumors Gastrointestinal Tumors Skin Cancer Others Market size by End User Ambulatory & Surgical Centers Hospitals Specialty Clinics OthersIf enquiry before buying this report @ http://orbisresearch.com/contacts/enquiry-before-buying/2293847 The study objectives of this report are: To study and analyze the global Intraoperative Radiation Therapy Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Intraoperative Radiation Therapy Systems are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units).
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research.
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global market.
Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083What the Market Looks Like?Predicted to grow at a CAGR of 7.0% during the forecast period, the global Intraoperative Radiation Therapy Market projected to reach USD 68 million by 2024 from USD 48 million in 2019Based on method, the market is segmented into electron IORT and intraoperative brachytherapy.
The electron IORT segment is expected to grow at the highest rate in the market in 2019.On the basis of application, the market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers.
The breast cancer application segment is expected to dominate the market during the forecast period.
This can be primarily attributed to factors such as the non-invasive nature of radiotherapy, rising incidence of breast cancer, and high success rates achieved with IORT.Get Sample Copy of This Report@https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083What Drives the Market?The growth of the global market for Intraoperative Radiation Therapy is primarily influenced by the following factors:• Growing Global Prevalence of Cancer• Technological Advancements• Advantages of IORT Over EBRTGeographical growth scenario of Intraoperative Radiation TherapyThe Asia Pacific region is one of the major revenue-generating regions in the market.
China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.
The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
This study involved the extensive use of both primary and secondary sources.Major Growth Drivers:The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.Expected Revenue Growth:[159 Pages Report] The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.COVID-19 Impact on the global Intraoperative radiation therapy marketThe intraoperative radiation therapy market was significantly impacted by the COVID-19 pandemic.
Various screening, diagnostic, and surgical procedures were restricted or postponed at hospitals and cancer treatment centers, which resulted in disruptions in the cancer diagnosis as well as treatment market.
The pandemic also impacted the availability of healthcare resources.
Major regulatory authorities across the globe, such as the CDC, WHO, MHRA, TGA, and EMA, have identified cancer patients at a greater risk of contracting coronavirus disease than healthy adults.Browse in-depth TOC on “Intraoperative Radiation Therapy Market”77 – Tables33 – Figures159 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083Growing global prevalence of cancerThe IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue.
This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy).
